Company intelligence / Profile preview
NuLife Pharmaceuticals
- Ownership
- Private
- Development stage
- Commercial
Overview
NuLife has a broad commercial portfolio with leading brands such as Soliwax Ear Drops for earwax removal and Salactin Paint for warts/corns. Their products are WHO GMP certified and widely used across India and exported internationally. No clinical trial data or novel drug development results are reported; focus is on generics/proprietary formulations.
- Therapeutic areas
- OtherDermatologyOphthalmologyWomen's Health
- Modalities
- Small molecules (tablets, capsules, oral solutions)Topical preparations (ointments, creams, lotions)Proprietary ayurvedic formulationsPoint-of-care diagnostics and medical devices (see note below on possible confusion with a similarly named company)
- Industry
- Biotech
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on NuLife Pharmaceuticals.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NuLife Pharmaceuticals.